Submit

Nippon India Nifty Pharma ETF

Back to Mutual Funds Research Page
Category: ETFs
Launch Date: 05-07-2021
Asset Class:
Benchmark: NIFTY Pharma TRI
Expense Ratio: 0.21% As on (31-05-2025)
Status: Open Ended Schemes
Minimum Investment: 1000.0
Minimum Topup: 0.0
Total Assets: 967.8 Cr As on (30-05-2025)
Turn over: 45
NAV as on 13-06-2025

22.4356

-0.05 (-0.2322%)

CAGR Since Inception

11.89%

NIFTY Pharma TRI 14.48%

PERFORMANCE of Nippon India Nifty Pharma ETF

Scheme Performance (%) Data as on - 13-06-2025

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Nippon India Nifty Pharma ETF 11.24 22.3 - - 11.89
Nifty Pharma TRI 12.36 21.89 17.97 7.6 14.48
ETFs 8.96 19.59 20.63 12.89 13.2

Yearly Performance (%)

Nav Movement

Fund Managers

Jitendra Tolani

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

RETURNS CALCULATOR for Nippon India Nifty Pharma ETF

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of Nippon India Nifty Pharma ETF

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Nippon India Nifty Pharma ETF 12.37 - -
ETFs - - - - - -

PEER COMPARISION of Nippon India Nifty Pharma ETF

Compare SIP Compare Lumpsum
Period
Data as on - 13-06-2025
Scheme Name Launch
Date		 1-Year
Ret (%)		 2-Yrs
Ret (%)		 3-Yrs
Ret (%)		 5-Yrs
Ret (%)		 10-Yrs
Ret (%)
Nippon India Nifty Pharma ETF 05-07-2021 11.24 30.61 22.3 0.0 0.0
Mirae Asset Hang Seng TECH ETF 06-12-2021 44.24 16.73 8.16 0.0 0.0
Nippon India ETF Hang Seng BeES 09-03-2010 39.71 16.76 11.13 4.68 4.09
Tata Gold Exchange Traded Fund 12-01-2024 38.61 0.0 0.0 0.0 0.0
LIC MF Gold Exchange Traded Fund 09-11-2011 38.06 28.29 23.92 15.26 13.22
Invesco India Gold Exchange Traded Fund 12-03-2010 37.83 27.86 23.44 14.95 12.95
Axis Gold ETF 10-11-2010 36.99 27.42 23.11 14.8 12.54
ICICI Prudential Gold ETF 05-08-2010 36.94 27.48 23.14 14.73 12.69
Aditya Birla Sun Life Gold ETF 13-05-2011 36.85 27.29 23.06 14.72 12.83
Zerodha Gold ETF 03-02-2024 36.76 0.0 0.0 0.0 0.0

PORTFOLIO ANALYSIS of Nippon India Nifty Pharma ETF

Asset Allocation (%)